Transpek Industry Ltd (506687)

Transpek Industry has informed the exchange that company officials will be meeting institutional investors and analysts in Mumbai on September 3, 2026. The meeting will be conducted in a physical group format starting at 4:00 PM IST. The company clarified that discussions will strictly be based on publicly available information without sharing any unpublished price sensitive information (UPSI).

• Investor Group Meeting scheduled for September 3, 2026, from 4:00 PM IST onwards
• Meeting format is physical in Mumbai
• Interaction will rely strictly on publicly available information with no UPSI shared

Transpek Industry reported Q1 FY27 revenue of ₹155.1 crore, down 6.5% YoY amid subdued global demand and pricing competition. International business contributed 84.4% of total revenue, with polymer applications accounting for 48.7% and specialty chemicals at 22.5%. The company is doubling its R&D team this fiscal year, building a 4-stream multipurpose pilot plant over the next 6-7 months, and preparing a feasibility report to acquire land in Odisha. With near-zero debt (D/E 0.08) and ₹768 crore in net worth, management plans to fund these value-added chemistry initiatives via internal accruals.

• Q1 FY27 revenue stood at ₹155.1 crore, down 6.5% YoY due to aggressive pricing and soft export demand.
• International markets accounted for 84.4% of quarterly revenues, led by North America.
• Polymers represented 48.7% of revenues, followed by specialty chemicals at 22.5% and pharmaceuticals at 10.11%.
• Setting up a 4-stream multi-purpose pilot plant within 6-7 months and doubling R&D talent and infrastructure in FY27.
• Pursuing land acquisition in a notified zone in Odisha; detailed feasibility study underway prior to board approval.

Transpek Industry Limited has informed the exchanges that the audio recording of its Investor Call held on August 20, 2026, at 4:00 PM has been made available on the company website. The disclosure is submitted pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. No direct financial figures or operational disclosures were included in this specific intimation letter.

• Investor Call conducted on August 20, 2026, at 4:00 PM
• Audio recording uploaded to the company website under Investor/Analyst Meet & Business Update Call Transcripts
• Filing submitted under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015

Transpek Industry released its August 2026 investor presentation detailing Q1 FY27 performance and strategic initiatives. Q1 FY27 total revenue came in at ₹155.1 crore (down 6.5% YoY, up 1.7% QoQ), while PAT fell 42.7% YoY to ₹8.9 crore, impacted by input price escalations in Sulphur and Chlorine along with elevated freight rates. The company highlighted that 84.4% of revenue is derived from international markets, led by North America at 52.0%. On growth initiatives, the Odisha Government approved the company's expression of interest for land acquisition for a new site, and the company plans to double its R&D team in FY27.

• Q1 FY27 total revenue at ₹155.1 cr (-6.5% YoY) with EBITDA of ₹24.1 cr (15.6% margin vs 21.5% in Q1 FY26)
• Q1 FY27 PAT stood at ₹8.9 cr, down 42.7% YoY but recovering 35.7% QoQ from ₹6.6 cr in Q4 FY26
• Exports contributed 84.4% of Q1 revenue, with North America at 52.0% and Europe at 16.9%
• Odisha Government approved company's expression of interest for land acquisition for a potential new manufacturing site
• Expanding into non-acid and non-alkyl chloride chemistries, with plans to double R&D team and infrastructure in FY27

Transpek Industry Limited has submitted its Annual Report for FY 2025-26 under Regulation 34 of SEBI LODR along with the notice for its 60th Annual General Meeting scheduled for September 15, 2026. The company reported an installed capacity of 66,000 MTPA with operations spanning 16 countries. International markets accounted for 83.1% of FY26 revenues, led by North America at 62.9% and Europe at 11.5%. A dividend of ₹20 per share has been declared for the financial year.

• Declared a dividend of ₹20 per equity share for FY 2025-26
• 60th Annual General Meeting scheduled for September 15, 2026 via Video Conferencing
• Total installed manufacturing capacity stands at 66,000 MTPA
• International markets contributed 83.1% of revenue in FY26, with North America at 62.90% and Europe at 11.50%
• Commercialized new acid chloride volumes and developing three non-acid chloride chemistries

Transpek Industry Limited has scheduled an earnings and business update conference call on Thursday, August 20, 2026, at 4:00 PM IST. The management, represented by Managing Director Mr. Bimal Mehta, will discuss the company's operational and financial performance. The call follows the recent Jun 2026 quarter results where the company reported net sales of ₹151.06 crore and a net profit of ₹8.93 crore.

• Earnings call scheduled for Thursday, 20th August, 2026 at 04:00 PM IST
• Intimation submitted under Regulation 30 of SEBI LODR Regulations on 17th August, 2026
• Management representation led by Mr. Bimal Mehta, Managing Director

Transpek Industry Limited has notified the exchanges regarding its 60th Annual General Meeting (AGM), scheduled for Tuesday, September 15, 2026, at 03:00 p.m. IST via Video Conferencing/OAVM. The company has fixed Monday, September 7, 2026, as the cut-off date to determine shareholder eligibility for remote e-voting and voting at the meeting. This is a standard statutory compliance filing without any direct immediate impact on financial performance or operations.

• 60th Annual General Meeting scheduled for September 15, 2026 at 03:00 p.m.
• Cut-off date for remote e-voting and AGM voting fixed as September 7, 2026
• AGM to be conducted via Video Conferencing or Other Audio Visual Means (VC/OAVM)

Transpek Industry's Board of Directors approved the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, in a meeting held on August 7, 2026. The company, which reported a TTM revenue of Rs 621 Cr and a PAT of Rs 46 Cr for FY26, is a player in the commodity chemicals space. While the specific financial figures for the June quarter were not detailed in this cover letter, the meeting concluded at 4:50 p.m. The trading window for insiders is scheduled to reopen on August 10, 2026.

• Board approved results for the quarter ended 30th June, 2026, on August 7, 2026
• Board meeting commenced at 2:00 p.m. and concluded at 4:50 p.m.
• Trading window for designated persons to re-open on 10th August, 2026
• Company reported TTM revenue of Rs 621 Cr and TTM PAT of Rs 46 Cr as of FY26

Transpek Industry's Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026, in a meeting held on August 7, 2026. The company enters the new fiscal year following a period of declining profitability, with quarterly PAT having dropped from Rs 15.58 Cr in June 2025 to Rs 6.58 Cr in March 2026. While the specific P&L figures for the current quarter were not detailed in the cover letter, the company's TTM revenue stands at Rs 621 Cr with an operating margin of 15%. Investors should closely examine the full results to see if the sequential decline in net profit has been arrested.

• Board meeting held on August 7, 2026, to approve standalone and consolidated results.
• Meeting duration was 2 hours and 50 minutes, concluding at 4:50 p.m.
• Trading window for insiders is scheduled to re-open on August 10, 2026.
• Company reported TTM revenue of Rs 621 Cr and TTM PAT of Rs 46 Cr prior to this result.
• Quarterly net profit trend showed a consistent decline over the previous four quarters (Rs 15.58 Cr to Rs 6.58 Cr).

Transpek Industry's Board of Directors met on August 7, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This follows a trailing twelve-month (TTM) period where the company generated Rs 621 Cr in revenue and Rs 46 Cr in PAT. The company currently maintains a low debt-to-equity ratio of 0.08 and a market capitalization of Rs 740 Cr. Investors should note the trading window is scheduled to re-open on August 10, 2026.

• Board meeting held on August 7, 2026, to approve Q1 FY27 financial results
• Trading window for insiders to re-open on August 10, 2026
• TTM revenue stands at Rs 621 Cr with an operating profit margin of 15.0%
• Company maintains a low debt profile with total debt of Rs 60 Cr against a net worth of Rs 768 Cr

Transpek Industry has scheduled a board meeting for August 7, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This announcement comes as the company faces a challenging period, with net profit declining from ₹15.58 Cr in June 2025 to ₹6.58 Cr in March 2026. The stock has seen a significant 37.3% price correction over the last 12 months. The trading window for designated persons, which closed on July 1, 2026, will remain shut until 48 hours after the results are declared.

• Board meeting scheduled for August 7, 2026, to approve Q1 results.
• Financial results cover the three-month period ended June 30, 2026.
• Trading window for insiders has been closed since July 1, 2026.
• Trading window to reopen 48 hours after the August 7 announcement.
• Company reported a TTM PAT of ₹46 Cr against a market cap of ₹573 Cr.

Transpek Industry has announced the resignation of Dr. Gurpreet Kaur, the Senior General Manager of Research & Development (R&D) and Quality Control (QC). Designated as Senior Management Personnel and HOD of R&D, her departure is attributed to professional circumstances. The resignation was tendered on July 13, 2026, with a requested relieving date of July 15, 2026. This change is significant as R&D is a core function for a specialty chemical company, though no successor has been named yet.

• Dr. Gurpreet Kaur resigned from her position as Senior GM (R&D and QC) on July 13, 2026.
• The resignation is effective from the close of business hours on July 15, 2026.
• The transition period is notably short, with only 2 days between the resignation date and the relieving date.
• Dr. Kaur served as the Head of Department (HOD) for R&D at the company's Ekalbara facility.

Transpek Industry has received authorization from the Indian Chemical Council (ICC) to use the 'Responsible Care' logo, a global chemical industry standard for safety and environmental performance. The certification is valid for a three-year term from July 2026 to June 2029. This is a reputational milestone that confirms the company's adherence to industry-best practices in health, safety, and environmental management. While positive for the company's ESG profile, it is a routine administrative update with no direct impact on financial performance.

• Certification valid for a period of 3 years from July 2026 to June 2029
• Issued by the Indian Chemical Council (ICC) under membership number ICC-WR/RM/T-03
• Assigned RC Logo Number 084 for the specified period
• The initiative focuses on environmental, health, safety, and security performance standards